White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio
Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
Eli Lilly’s $2.4 Billion Pending Acquisition of DICE THerapeutics
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
Amphastar’s $1.075 Billion Acquisition of BAQSIMI from Eli Lilly
Wilson, Sonsini is acting as legal counsel to Amphastar. Kirkland & Ellis and Covington & Burling are acting as legal counsel to Lilly. In an effort...
VSP Vision’s Acquisition of Professional Eye Care Associates of America
Kirkland & Ellis advised VSP Vision, while Locke Lord advised PECAA and Nautic Partners on the deal. VSP Vision, the first and only national not-for-profit vision...
ADTRAN’s Business Combination with ADVA
Kirkland & Ellis and Blomstein represented ADTRAN in the transaction. Hogan Lovells advised ADVA Optical. Cleary Gottlieb Steen & Hamilton advised BofA Securities. Skadden Arps Slate...